Table 1.
This study | Choi, 2010 (22)a | Kim, 2012 (23) | Kim, 2010 (24)a | Koltin, 2016 (25) | Lim-Dunham, 2017 (26) | Norlen, 2014 (32)b | Park, 2009 (27) | Park, 2010 (28) | Park, 2012 (29) | Wienke, 2003 (30) | Grani, 2017 (31) | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nodules | Set 1: 501 | Set 2: 554 | 204 | 80 | 133 | 27 (pediatric pop.) | 39 (pediatric population) | 141 (AUS/FLUS) | 52 (all malignant) | 133 | 400 | 70 | 49 (AUS/FLUS/FN) | ||
Statistics | Krippendorff alpha | Kappa | Kappa | Kappa | Kappa | Kappa | Kappa | Spearman corr. | Kappa | Kappa | Kappa | Krippendorff alpha | |||
Observers | 2 clinicians, same level of experience | 4 exp. radiologists, same institution | 7 resident radiologists, 2 different units | 9 | 5 faculty radiologists | 4 residents | 3 exp. radiologists | 2 exp. radiologists | 2 trained surgeons | 3 radiologists (1–7 year exp.) | 5 radiologists (1-–6 6year exp.) | 3 radiologists (7-–10 10year exp.), different institution | 2 radiologists | 3 clinicians, 2 different units | |
Echogenicity | 0.56 (0.46-–0.66) | 0.66 (0.59-–0.73) | 0.45 | 0.5 | 0.46 | 0.57 | 0.34 | 0.46 | 0.54 (0.37-–0.73) | 0.94 | 0.04–0.45 | 0.57 | 0.504 | 0.37 | 0.58 (0.45–0.70) |
Composition | 0.52 (0.34–0.68) | 0.5 (0.29–0.68) | 0.59 | 0.48 | 0.36 | 0.64 | 0.18 | N/A | 0.8 (0.53–0.99) | N/A | 0.70–1.00 | 0.64 | 0.818 | 0.62 | 0.5 (0.29–0.68) |
Shape | N/A | N/A | 0.61 | 0.57 | 0.4 | 0.46 | 0.34 | N/A | 0.29 (0.01–0.72) | 0.61 | 0.48–0.79 | 0.42 | 0.42 | N/A | N/A |
Margin | 0.51 (0.43–0.58) | 0.44 (0.34–0.53) | 0.61 | 0.49 | 0.25 | 0.4 | 0.19 | 0.58 | 0.6 (0.4–0.79) | 0.6 | 0.03–0.29 | 0.34 | 0.33 | 0.13 | 0.57 (0.43–0.70) |
Vascularity | N/A | N/A | 0.46 | N/A | N/A | N/A | N/A | 0.18 | 0.76 (0.52–0.99) | 0.74 | N/A | N/A | N/A | 0.75 | N/A |
Calcification | 0.8 (0.63–0.93) | 0.89 (0.75–1) | 0.58 | 0.62 | 0.47 | 0.63 | 0.42 | N/A | N/A | N/A | 0.47–0.62 | 0.55 | 0.479 | 0.91 | 0.68 (0.46–0.88) |
Micro- | 0.49 (−0.28–1) | 0.39 (−0.49–1) | 0.51 | 0.59 | N/A | N/A | N/A | 0.59 | N/A | 0.79 | N/A | 0.54 | N/A | N/A | N/A |
Macro- | 0.85 (0.59–1) | 0.83 (0.6–1) | 0.39 | 0.39 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.4 | N/A | N/A | N/A |
Echogenic foci | 0.48 (0.3–0.64) | 0.35 (0.17–0.52) | N/A | N/A | N/A | N/A | N/A | N/A | 0.77 (0.56–0.99) | N/A | N/A | N/A | N/A | N/A | 0.34 (0.12–0.56) |
Capsule invasion | 0.11 (−0.91–1) | 0.4 (−1–1) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.32 | N/A | N/A | 0.32 (–0.61–1.0) |
aMaximum k value reported in any of the two sessions; bAll features were grouped in two classes.
AUS/FLUS, Atypia of Undetermined Significance or Follicular Lesion of Undetermined Significance; FN, Follicular Neoplasm; N/A, not available.